Kawasaki disease following immunization reported to the Canadian Immunization Monitoring Program ACTive (IMPACT) from 2013 to 2018.

MLA

Alsager, Khaled, et al. “Kawasaki Disease Following Immunization Reported to the Canadian Immunization Monitoring Program ACTive (IMPACT) from 2013 to 2018.” Human Vaccines & Immunotherapeutics, vol. 18, no. 5, Nov. 2022, p. 2088215. EBSCOhost, https://doi.org/10.1080/21645515.2022.2088215.

APA

Alsager, K., Khatri Vadlamudi, N., Jadavji, T., Bettinger, J. A., Constantinescu, C., Vaudry, W., Tan, B., Sauvé, L., Sadarangani, M., Halperin, S. A., & Top, K. A. (2022). Kawasaki disease following immunization reported to the Canadian Immunization Monitoring Program ACTive (IMPACT) from 2013 to 2018. Human Vaccines & Immunotherapeutics, 18(5), 2088215. https://doi.org/10.1080/21645515.2022.2088215

Chicago

Alsager, Khaled, Nirma Khatri Vadlamudi, Taj Jadavji, Julie A Bettinger, Cora Constantinescu, Wendry Vaudry, Ben Tan, et al. 2022. “Kawasaki Disease Following Immunization Reported to the Canadian Immunization Monitoring Program ACTive (IMPACT) from 2013 to 2018.” Human Vaccines & Immunotherapeutics 18 (5): 2088215. doi:10.1080/21645515.2022.2088215.